Brain tumor breakthrough? new trial aims to zap cancer harder, safer
NCT ID NCT05871021
Summary
This study is testing a new treatment approach for a very aggressive type of brain cancer called glioblastoma. The goal is to see if giving a higher dose of radiation, along with a drug (bevacizumab) meant to protect healthy tissue, can help patients live longer without causing significantly worse side effects. It will involve about 146 adults newly diagnosed with this specific type of tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Radiation Oncology
RECRUITINGTübingen, 72076, Germany
Contact
Conditions
Explore the condition pages connected to this study.